SecBot SecBot
SECBOTREPLAY Home › Report › INM

INM · InMed Pharmaceuticals' S-3 shelf registration has become effective,…

InMed Pharmaceuticals Inc. · EFFECT filed Mar 31, 2026 at 00:15 ET

At the news

BEARISHIMPACT 7/10

EFFECT filed Mar 31, 2026 at 00:15 ET

InMed Pharmaceuticals' S-3 shelf registration has become effective, allowing the company to raise up to $50 million through future offerings of common shares, preferred shares, warrants, or other securities. Given the company's $2 million market cap and existing going concern doubts, this creates a significant dilution overhang.

  • S-3 shelf registration became effective on March 30, 2026
  • Company may raise up to $50 million in aggregate value over time
  • Offering can include common stock, preferred stock, warrants, subscription rights, or units
  • Market cap is only $2 million, implying potential for extreme dilution

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access